Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mass hepatitis b screening aims to prevent liver cancer in thailand

NCT ID NCT07258251

First seen Dec 12, 2025 · Last updated May 23, 2026 · Updated 24 times

Summary

This study will screen nearly 240,000 adults in Phichit, Thailand, who were born before 1992 and may have undiagnosed hepatitis B. Those who test positive will be linked to care and offered a daily antiviral pill to control the virus and prevent liver damage. The goal is to find infected individuals early and keep them on treatment to reduce the risk of cirrhosis and liver cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Phichit Provincial Hospital, Phichit / 12 District Hospitals in Phichit Province

    Phichit, Changwat Phichit, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.